Loading…
From Biology to Therapy: Improvement of Therapeutic Options for Clinical Care in Sickle Cell Disease
Friday, June 15 • 1:00pm - 2:20pm
The Cognitive Consequences of Sickle Cell Disease - What is Executive Functioning Anyway, and are there Medical Therapies to Address Cognitive Deficits?

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
Issues of Neurocognition in SCD
This session highlights the challenges posed by neurocognition issues for people living with sickle cell disease.

Overview of Neurocognition (1:00 - 1:10 PM)- Lanetta Bronté, President, Foundation for Sickle Cell Disease Research: This segment will serve as the level setting for the audience, many of whom will not be familiar with the topic. Neurocognition will be defined and along with some of the terms and concepts that are used commonly such as executive function, processing speed, working memory, attention deficit, and IQ. The segment will set the overarching issue for people living with sickle cell disease.

Executive Functioning in SCD Youth (1:10-1:35) - Carlton Dampier, Emory University: This segment will focus on how issues of neurocognition complicate pediatric to adult transition. The presentation will include approaches that can facilitate the transition.

Cognitive Challenges (1:35-2:00)-  Allison King, Washington University in St. Louis: Cognitive challenges in sickle cell disease start as early as infancy and progressively declines into adulthood. 
2:00 - 2:20 - Open Questions and Audience Input 



Open Questions and Audience Input
Session Objectives:
 Participants will become familiar with the neuropsychological deficits of adults and children with sickle cell disease based on neuropsychological evaluations.

Participants will become aware of the accommodations needed for children with sickle cell disease in school.

Participants will be provided with cases of children with this condition in terms of similarities and differences and evaluation results.


Moderators
avatar for Lanetta Bronté-Hall, MD, MPH, MSPH

Lanetta Bronté-Hall, MD, MPH, MSPH

President, Foundation for Sickle Cell Disease Research

Speakers
CD

Carlton Dampier, MD

Global Blood Therapeutics
avatar for Allison King, MD, MPH, PhD

Allison King, MD, MPH, PhD

Associate Professor of Pediatrics, Occupational Therapy, Washington University in St. Louis, School of Medicine


Friday June 15, 2018 1:00pm - 2:20pm CDT
Thurgood Marshall South West